Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis

Conditions:   Primary Biliary Cholangitis;   Primary Biliary Cirrhosis;   Cholangitis;   Cholestasis;   Biliary Tract Diseases;   Bile Duct Stricture Intervention:   Drug: HTD1801 (BUDCA) Sponsor:   HighTide Biopharma Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials